Key facts
- Notable investors include QAI Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for PexMachina
- ·The full record, as it builds
Funding rounds
No funding rounds for PexMachina are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PexMachina
Operator of a quantum simulation platform designed for pharmaceutical companies to accelerate the discovery of precision cancer treatments. The company combines advanced quantum computing simulations with oncology-specific drug design, enabling pharmaceutical firms to cut the time, cost, and risk of drug development.
- Sector
- Healthcare
- HQ
- DE
- Founded
- 2025
- Employees
- 2
- Website
- pexmachina.com/
- Ownership
- Privately Held (backing)
PexMachina doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PexMachina shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PexMachina in its N-PORT filings yet. We sweep new filings monthly.